CAS: 260779-88-2; Cisapridemonohydrate

该化合物是主要用作增进胃肠道运动的植入剂的制药化合物,属于替代苯丙胺类,具有选择性的血清素5-HT4受体激动剂作用,促进胃肠胃道释放乙酰胆碱,促进气气排空,改善食道运动功能,使其有利于胃复流疾病和功能性痢疾等条件.单水分形式表明该化合物含有每粒氨酸盐分子的水分子,可影响其溶解性和稳定性.Cisapride在水中具有相对较低的溶解性,可影响到其生物利用率.然而,必须指出,对心脏的严重侧面效应与许多国家的严重的心脏作用有关,导致其退出市场.因此,其使用现在有限,而且受到临床环境的严密监测.总体而言,对精酸单水的单水化合物具有临界特征,其结构特征和安全性特征是其临界特征.

结构式图片

欧盟法规

C&L通报

合成工艺路线路线简述

    海关参考信息

    专利信息


    专利号:US-9353057-B2
    优先权日:2003-12-30
    标 题:Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
    发明人:GALLOP MARK A; DAI XUEDONG; SCHEUERMAN RANDALL A; RAILLARD STEPHEN P; MANTHATI SURESH K; YAO FENMEI; PHAN THU; LUDWIKOW MARIA; PENG GE; BHAT SEEMA
    权利人:XENOPORT INC
    摘要:Methods for synthesis of 1-(acyloxy)-alkyl carbamates, particularly, the synthesis of 1-(acyloxy)-alkyl carbamate prodrugs of primary or secondary amine-containing drugs are described. Also described are methods for synthesis of 1-(acyloxy)-alkyl N-hydroxysuccinimidyl carbonates which are useful intermediates in the synthesis of 1-(acyloxy)-alkyl carbamates are also described.

    专利号:US-7211590-B2
    优先权日:2002-08-01
    标 题:Nitrosated proton pump inhibitors, compositions and methods of use
    发明人:FANG XINQIN; GARVEY DAVID S; LETTS L GORDON
    权利人:NITROMED INC
    摘要:The invention describes novel nitrosated proton pump inhibitor compounds and pharmaceutically acceptable salts thereof, and novel compositions comprising at least one nitrosated proton pump inhibitor compound, and, optionally, at least one compound that donates, transfers or releases nitric oxide, stimulates endogenous synthesis of nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor or is a substrate for nitric oxide synthase, and/or at least one therapeutic agent. The invention also provides novel compositions comprising at least one nitrosated proton pump inhibitor compound, and at least one compound that donates, transfers or releases nitric oxide, elevates endogenous levels of endothelium-derived relaxing factor, stimulates endogenous synthesis of nitric oxide or is a substrate for nitric oxide synthase and/or at least one therapeutic agent. The invention also provides novel kits comprising at least one nitrosated proton pump inhibitor compound, and, optionally, at least one nitric oxide donor and/or at least one therapeutic agent. The invention also provides methods for treating gastrointestinal disorders; facilitating ulcer healing; decreasing the recurrence of ulcers; improving gastroprotective properties, anti-Helicobacter pylori properties or antacid properties of proton pump inhibitors; decreasing or reducing the gastrointestinal toxicity associated with the use of nonsteroidal antiinflammatory compounds; treating bacterial infections and/or viral infections.

    专利号:US-7807349-B2
    优先权日:2002-11-29
    标 题 :Protein synthesis monitoring (PSM)
    发明人:SMILANSKY ZEEV
    权利人:ANIMA CELL METROLOGY
    摘要:A method and a device are disclosed for monitoring the synthesis of proteins by the ribosome in real time, in vivo as well as in in-vitro. The ribosome is engineered to carry a donor fluorophore, and tRNA and/or amino acids and/or some other part of the ribosome are either engineered to carry acceptor fluorophores or else their natural fluorescent properties are utilized as acceptors. As the ribosomes mechanism processed the mRNA and tRNA molecules and synthesizes a polypeptide chain, a light source illuminates the ribosome, exciting the donor fluorophores and thereby the acceptor fluorophores whenever these are in sufficient proximity to a donor. The resulting signals are detected and used as a key for real-time database searching and identification of the protein being synthesized. The resulting data can be tabulated and interpreted in different ways. FIG. ( 1 ) describes the properties of a FRET pair and the dependence of FRET on pair distance.

    专利号:US-8442773-B2
    优先权日:2002-11-29
    标题:Protein synthesis monitoring (PSM)
    发明人:SMILANSKY ZEEV
    权利人:SMILANSKY ZEEV; ANIMA CELL METROLOGY
    摘要:A method and a device are disclosed for monitoring the synthesis of proteins by the ribosome, wherein the ribosome is bound to a first label, for example a donor fluorophore, and a tRNA and/or amino acid are is bound to a second label, for example an acceptor fluorophore, wherein the first and second labels together from a FRET pair. As the ribosome mechanism processes the mRNA and tRNA molecules and synthesizes a polypeptide chain, a light source illuminates the ribosome, exciting the donor fluorophores and thereby the acceptor fluorophores whenever these are in sufficient proximity to a donor. The resulting signals are detected and used as a key for database searching and identification of the protein being synthesized.

    专利号:US-6218542-B1
    优先权日:1996-10-15
    标 题:Synthesis of cisapride
    发明人:DE KNAEP ALFONS GASTON MARIA; MOENS LUC JOZEF RAPHAEL; REY MAX
    权利人:JENSSEN PHARMACEUTICA, N V
    摘要:A new Process of preparing cisapride, and the pharmaceutically acceptable acid addition salts thereof, by reductively aminating 1-[3-(4-fluorophenoxy)-propyl]-3-methoxy-4-piperidinone in the presence of benzylamine under hydrogen in a reaction-inert solvent, yielding 1-[3-(4-fluorophenoxy)-propyl]-3-methoxy-4-piperidinamine having a cis/trans ratio of about 93/7, which is enriched in the amount of cis-stereoisomer by converting it into its acid addition salt, by treatment with a suitable inorganic acid, in an appropriate solvent, subsequent crystallisation and conversion to its free base form by treatment with an appropriate base, yielding 1-[3-(4-fluorophenoxy)-propyl]-3-methoxy-4-piperidinamine having a cis/trans ratio of equal to or higher than 98/2.

    专利号:US-2008267981-A1
    优先权日:2004-06-30
    标题:Compositions and Methods for Delivery of Antitumor Agents
    发明人:JANDA KIM D; WIRSCHING PETER; BOGER DALE L
    权利人:SCRIPPS RESEARCH INST
    摘要:Methods for treating a neoplastic disease with an antibody-cytotoxin conjugate molecule, methods of synthesizing an antibody-cytotoxin conjugate molecule are provided. Compounds that are useful as antibody-cytotoxin conjugate molecule or useful in the synthesis of these molecules are also provided.

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    主要参考文献


    1: Zhou X, Zhang Q, Zhao T, Bai X, Yuan W, Wu Y, Liu D, Li S, Ju J, Chege Gitau S, Chu W, Xu C, Lu Y. Cisapride protects against cardiac hypertrophy via inhibiting the up-regulation of calcineurin and NFATc-3. Eur J Pharmacol. 2014 Jul 15;735:202-10. doi: 10.1016/j.ejphar.2014.04.012. Epub 2014 Apr 21. doi: 10.1186/2050-6511-15-14.
    3: Mt-Isa S, Tomlin S, Sutcliffe A, Underwood M, Williamson P, Croft NM, Ashby D. Prokinetics prescribing in paediatrics: evidence on cisapride, domperidone, and metoclopramide. J Pediatr Gastroenterol Nutr. 2015 Apr;60(4):508-14. doi: 10.1097/MPG.0000000000000657. doi: 10.2460/ajvr.75.4.361. doi: 10.1002/14651858.CD007780.pub2. Review. doi: 10.1111/j.1751-2980.2011.00491.x. Review. doi: 10.2460/ajvr.77.8.818. doi: 10.1016/j.saa.2012.10.071. Epub 2012 Nov 23. doi: 10.1177/1049909112457238. Epub 2012 Sep 9. Review. doi: 10.1002/14651858.CD002300.pub2. Review. Review. French. Review. doi: 10.1111/j.1651-2227.2008.01158.x. Epub 2008 Dec 10. Review.

    合成参考文献


    摘要:Veterinary and Human Toxicology., 39(231), 1997 []
    摘要:Veterinary and Human Toxicology., 38(118), 1996 []
    摘要:
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知